Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 5/2010

01-10-2010 | Research article

Drug related problems after discharge from an Australian teaching hospital

Authors: Glena R. Ellitt, Ellinor Engblom, Parisa Aslani, Tommy Westerlund, Timothy F. Chen

Published in: International Journal of Clinical Pharmacy | Issue 5/2010

Login to get access

Abstract

Objective To reconcile patients’ medicines and to classify drug related problems identified during medication review conducted after discharge from hospital. Setting Patients were discharged from the cardiology unit of Westmead Hospital after recruitment into the Westmead Medicines Project which ran from 2004 to 2007. Method This retrospective study involved an analysis of drugs, diseases and drug related problems in medication review reports available for 76 out of 85 patients who received a Home Medicines Review (HMR). Data sources for medication reconciliation and analyses also included hospital discharge summaries (n = 70) and GP referrals for HMR (n = 44). Comprehensive clinical profiles were constructed for the 76 subjects whose drug related problems were identified, coded, and then classified from their HMR reports. Main outcome measures Number, type, distribution and international classification of drugs, diseases and drug-related problems. Results Patients were prescribed drugs for a broad range of cardiovascular, circulatory, endocrine, respiratory and digestive system diseases. Mean number of drugs per patient in discharge summaries: 8.7 ± SD 3.3 (range 3–19); in GP referrals: 8.9 ± SD 4.3 (range 2–23); and in HMR reports: 10.8 ± SD 4.0 (range 3–24). Mean number of diseases per patient in discharge summaries: 4.1 ± SD 2.9 (range 1–11); and in HMR reports: 4.7 ± SD 2.6 (range 1–12). A total of 398 drug related problems were identified for 71 (93.3%) patients with mean 5.6 ± SD 4.3 problems (range 1–21). The most frequently recorded problems were the patients’ uncertainty about drug aim: n = 128 (32.0%); potential interactions n = 89 (22.4%); and adverse reactions n = 60 (15.1%). Conclusion This study showed that patients recently discharged from a tertiary care hospital had a significant number of drug related problems. Classification of drugs and diseases revealed a broad range of non-cardiovascular medicines and conditions in the patients from an acute care cardiology unit. We found that home medicines review provided continuity of care and an opportunity for medication reconciliation which revealed marked differences in number of drugs, between hospital discharge and medicines review. The patients’ uncertainly about their drugs and their diverse range of co-morbidities indicated the need for timely counselling by pharmacists in the community.
Literature
1.
go back to reference Roughead EE, Semple SJ. Medication safety in acute care in Australia: where are we now? Part 1: a review of the extent and causes of medication problems 2002–2008. Aust New Zealand Health Policy. 2009;6:18. doi:10.1186/1743-8462-6-18.CrossRefPubMed Roughead EE, Semple SJ. Medication safety in acute care in Australia: where are we now? Part 1: a review of the extent and causes of medication problems 2002–2008. Aust New Zealand Health Policy. 2009;6:18. doi:10.​1186/​1743-8462-6-18.CrossRefPubMed
2.
go back to reference Stewart S, Pearson S, Luke CG, Horowitz JD. Effects of home-based intervention on unplanned re-admissions and out-of hospital deaths. J Am Geriatr Soc. 1998;46:174–80.PubMed Stewart S, Pearson S, Luke CG, Horowitz JD. Effects of home-based intervention on unplanned re-admissions and out-of hospital deaths. J Am Geriatr Soc. 1998;46:174–80.PubMed
5.
go back to reference Paulino EI, Bouvy ML, Gastelurrutia MA, Buurma H, ESCP-SIR Rejkjavik Community Pharmacy Research Group. Drug related problems identified by European community pharmacists in patients discharged from hospital. Pharm World Sci. 2004;26:353–60.PubMed Paulino EI, Bouvy ML, Gastelurrutia MA, Buurma H, ESCP-SIR Rejkjavik Community Pharmacy Research Group. Drug related problems identified by European community pharmacists in patients discharged from hospital. Pharm World Sci. 2004;26:353–60.PubMed
6.
go back to reference de Koning JS, Klazinga NS, Koudstaal PJ, Prins A, Dippel DW, Heeringa J, et al. Quality of care in stroke prevention: results of an audit study among general practitioners. Prev Med. 2004;38:129–36.CrossRefPubMed de Koning JS, Klazinga NS, Koudstaal PJ, Prins A, Dippel DW, Heeringa J, et al. Quality of care in stroke prevention: results of an audit study among general practitioners. Prev Med. 2004;38:129–36.CrossRefPubMed
8.
go back to reference Hovell MF, Geary DC, Black DR, Kamachi K, Kirk R, Elder J. Experimental analysis of adherence counseling: implications for hypertension management. Prev Med. 1985;14:648–54.CrossRefPubMed Hovell MF, Geary DC, Black DR, Kamachi K, Kirk R, Elder J. Experimental analysis of adherence counseling: implications for hypertension management. Prev Med. 1985;14:648–54.CrossRefPubMed
9.
12.
go back to reference Dunbar SB, Mensah GA, Labarthe DR, Dunbar SB, Mensah GA, Labarthe DR. Building bridges: a partnership between professional nursing and the centers for disease control and prevention to reduce the burden of heart disease and stroke. Am J Prev Med. 2005;29:122–7.CrossRefPubMed Dunbar SB, Mensah GA, Labarthe DR, Dunbar SB, Mensah GA, Labarthe DR. Building bridges: a partnership between professional nursing and the centers for disease control and prevention to reduce the burden of heart disease and stroke. Am J Prev Med. 2005;29:122–7.CrossRefPubMed
13.
go back to reference Krska J, Cromarty JA, Arris F, Jamieson D, Hansford D, Duffus PR, et al. Pharmacist-led medication review in patients over 65: a randomized, controlled trial in primary care. Age Ageing. 2001;30:205–11. doi.org/10.1093/ageing%2F30.3.205. Krska J, Cromarty JA, Arris F, Jamieson D, Hansford D, Duffus PR, et al. Pharmacist-led medication review in patients over 65: a randomized, controlled trial in primary care. Age Ageing. 2001;30:205–11. doi.org/10.​1093/​ageing%2F30.​3.​205.
16.
go back to reference Emblen G, Miller E. Home medicines review. Aust Fam Physician. 2004;33:49–51.PubMed Emblen G, Miller E. Home medicines review. Aust Fam Physician. 2004;33:49–51.PubMed
19.
go back to reference Chabot I, Moisan J, Gregoire JP, Milot A. Pharmacist intervention program for control of hypertension. [see comment]. Ann Pharmacother. 2003;37:1186–93. doi.org/10.1345/aph.1C267. Chabot I, Moisan J, Gregoire JP, Milot A. Pharmacist intervention program for control of hypertension. [see comment]. Ann Pharmacother. 2003;37:1186–93. doi.org/10.​1345/​aph.​1C267.
25.
go back to reference Westerlund T, Almarsdóttir AB, Melander A. Drug-related problems and pharmacy interventions in community practice. Int J Pharm Pract. 1999;7:40–50. Westerlund T, Almarsdóttir AB, Melander A. Drug-related problems and pharmacy interventions in community practice. Int J Pharm Pract. 1999;7:40–50.
28.
go back to reference Letrilliart L, Hanslik T, Biour M, Fagot JP, Guiguet M, Flahault A. Post discharge adverse drug reactions in primary care originating from hospital care in France: a nationwide prospective study. Drug Saf. 2001;24:781–92.CrossRefPubMed Letrilliart L, Hanslik T, Biour M, Fagot JP, Guiguet M, Flahault A. Post discharge adverse drug reactions in primary care originating from hospital care in France: a nationwide prospective study. Drug Saf. 2001;24:781–92.CrossRefPubMed
30.
go back to reference Hamdy RC, Moore SW, Whalen K, Donnelly JP, Compton R, Testerman F, et al. Reducing polypharmacy in extended care. South Med J. 1995;88:534–8.PubMed Hamdy RC, Moore SW, Whalen K, Donnelly JP, Compton R, Testerman F, et al. Reducing polypharmacy in extended care. South Med J. 1995;88:534–8.PubMed
31.
go back to reference Bernsten C, Bjorkman I, Caramona M, Crealey G, Frokjaer B, Grundberger E, et al. Improving the well-being of elderly patients via community pharmacy-based provision of pharmaceutical care: a multicentre study in seven European countries. Drugs Aging. 2001;18:63–77.CrossRefPubMed Bernsten C, Bjorkman I, Caramona M, Crealey G, Frokjaer B, Grundberger E, et al. Improving the well-being of elderly patients via community pharmacy-based provision of pharmaceutical care: a multicentre study in seven European countries. Drugs Aging. 2001;18:63–77.CrossRefPubMed
33.
go back to reference Sturgess IK, McElnay JC, Hughes CM, Crealey G. Community pharmacy based provision of pharmaceutical care to older patients. Pharm World Sci. 2003;25:218–26.CrossRefPubMed Sturgess IK, McElnay JC, Hughes CM, Crealey G. Community pharmacy based provision of pharmaceutical care to older patients. Pharm World Sci. 2003;25:218–26.CrossRefPubMed
Metadata
Title
Drug related problems after discharge from an Australian teaching hospital
Authors
Glena R. Ellitt
Ellinor Engblom
Parisa Aslani
Tommy Westerlund
Timothy F. Chen
Publication date
01-10-2010
Publisher
Springer Netherlands
Published in
International Journal of Clinical Pharmacy / Issue 5/2010
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-010-9406-9

Other articles of this Issue 5/2010

International Journal of Clinical Pharmacy 5/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine